Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Current Status, Challenges, and Future Perspectives.

Cancer Med · 2026 · PMC13140983 · PMID 41876949

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

84.3%) in the apatinib plus chemotherapy group showed an increasing trend, no statistically significant differences were observed in these two indices between the two groups [ 97 ].

also in 63,971 other papers

showed a trendno p-value reported

Kohei Shitara from the National Cancer Center Hospital in Japan led the mid‐term results of the KEYNOTE‐585 study, and the final result demonstrated that neoadjuvant/adjuvant Pembrolizumab combined with FLOT is feasible in the perioperative treatment of locally advanced G/GEJ adenocarcinoma and showed a trend towards improved OS for patients [ 72 , 73 , 74 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.